UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001661
Receipt number R000002005
Scientific Title Hypertesive Patient in Hokuriku area research of Candesartan
Date of disclosure of the study information 2009/01/28
Last modified on 2010/07/27 09:55:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Hypertesive Patient in Hokuriku area research of Candesartan

Acronym

HAKUSAN

Scientific Title

Hypertesive Patient in Hokuriku area research of Candesartan

Scientific Title:Acronym

HAKUSAN

Region

Japan


Condition

Condition

hypertension

Classification by specialty

Medicine in general Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm the efficacy of Candesartan on BP and HR of hypertensive patients

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase IV


Assessment

Primary outcomes

decreament of heart rate

Key secondary outcomes

decreament of BNP
achievement of targeted BP
variation of serum K and Cr


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

candesartan

Interventions/Control_2

other ACE-I and/or ARB

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) outpatient whose resting BP is not achieved 135/80

(2)whose hypertension is treatment naive or treated by ACE-I and/or ARB

(3)who is eligible for written consent

Key exclusion criteria

whose hypertension is treated by other agents rather than ACE-I and/or ARB

Target sample size

500


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kondo Kunio

Organization

Ishikawa Medical Association

Division name

Ishikawa Internal Medicine Association

Zip code


Address

Kuratsuki-higashi 2-48, Kanazawa

TEL

076-239-3800

Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Ishikawa Internal Medicine Association

Division name

Ishikawa Internal Medicine Association

Zip code


Address


TEL


Homepage URL


Email

inano-heart@bpost.plala.or.jp


Sponsor or person

Institute

Ishikawa Internal Medicine Association

Institute

Department

Personal name



Funding Source

Organization

not applicable

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 01 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 12 Month 24 Day

Date of IRB


Anticipated trial start date

2009 Year 01 Month 01 Day

Last follow-up date

2010 Year 12 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 01 Month 27 Day

Last modified on

2010 Year 07 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002005


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name